Nationwide Fund Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-38,751
Closed -$988K 2493
2017
Q3
$988K Buy
38,751
+20,209
+109% +$464K ﹤0.01% 1785
2017
Q2
$313K Sell
18,542
-24,529
-57% -$336K ﹤0.01% 2426
2017
Q1
$629K Buy
43,071
+1,976
+5% +$29.3K ﹤0.01% 2035
2016
Q4
$584K Buy
41,095
+474
+1% +$7.34K ﹤0.01% 2095
2016
Q3
$711K Buy
40,621
+24,518
+152% +$407K ﹤0.01% 1985
2016
Q2
$275K Buy
16,103
+843
+6% +$15.1K ﹤0.01% 2460
2016
Q1
$317K Sell
15,260
-663
-4% -$10.6K ﹤0.01% 2311
2015
Q4
$303K Buy
15,923
+229
+1% +$4.67K ﹤0.01% 2349
2015
Q3
$300K Hold
15,694
﹤0.01% 2371
2015
Q2
$728K Sell
15,694
-1,985
-11% -$86.1K ﹤0.01% 2038
2015
Q1
$773K Buy
17,679
+898
+5% +$41.7K ﹤0.01% 2019
2014
Q4
$582K Sell
16,781
-142
-0.8% -$5.76K ﹤0.01% 2095
2014
Q3
$709K Buy
16,923
+4
+0% +$179 ﹤0.01% 2011
2014
Q2
$991K Buy
+16,919
New +$1.07M ﹤0.01% 1870
2014
Q1
Sell
-16,850
Closed -$986K 3230
2013
Q4
$986K Sell
16,850
-465
-3% -$24.3K ﹤0.01% 1879
2013
Q3
$913K Buy
17,315
+826
+5% +$55.5K ﹤0.01% 1887
2013
Q2
$1.27M Buy
+16,489
New +$1.35M 0.01% 1561

Other funds holding ARNA

Nationwide Fund Advisors's ARNA Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2017, closing a stake of 38,751 shares — an estimated $988K sold.

Nationwide Fund Advisors first reported a position in ARNA in Q2 2013 and held it in 17 quarters. The position peaked at $1.27M in Q2 2013. 125 funds tracked by Wall St. Rank hold ARNA as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 38,751 Arena Pharmaceuticals Inc shares in Q4 2017, an estimated $988K.
  • Nationwide Fund Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 17 quarters.
  • Nationwide Fund Advisors's Arena Pharmaceuticals Inc position peaked at $1.27M in Q2 2013.
  • 125 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.